SCHEMBL2728297

SCHEMBL2728297

CC(=CCCC=CCc1c(O)c(Cl)c(C)c(C=O)c1O)COC(=O)C(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 15/20 0.53
▸ MAOB P27338 1/20 0.38
▸ IMPDH2 P12268 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2728293 1.00 DHODH (0.53) DHODHMAOBIMPDH2
SCHEMBL2724967 0.88 DHODH (0.70) DHODHIMPDH2
SCHEMBL2724970 0.88 DHODH (0.70) DHODHIMPDH2
SCHEMBL2726809 0.81 DHODH (0.45) DHODHMAOB
SCHEMBL2726812 0.81 DHODH (0.45) DHODHMAOB
SCHEMBL2727740 0.81 DHODH (0.63) DHODHIMPDH2
SCHEMBL2727737 0.81 DHODH (0.63) DHODHIMPDH2
SCHEMBL2727615 0.80 MAOB (0.55) DHODHMAOB
SCHEMBL2727611 0.80 MAOB (0.55) DHODHMAOB
SCHEMBL2725436 0.78 DHODH (0.64) DHODHIMPDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9440913-B2 Dihydroxybenzene derivatives and antiprotozoal agent comprising same as active ingredient NAI INC. (JP) 2016-09-13 — — US claimed
US-9737504-B2 Dihydroorotic and acid dehydrogenase inhibitor INSTITUTE OF MITOCHONDRIA SCIENCE, INC. (JP) 2017-08-22 — — US disclosed
US-20160296494-A1 DIHYDROOROTIC AND ACID DEHYDROGENASE INHIBITOR NAI INC. 2016-10-13 — — US disclosed
US-9440913-B2 Dihydroxybenzene derivatives and antiprotozoal agent comprising same as active ingredient NAI INC. (JP) 2016-09-13 — — US disclosed
WO-2013180140-A1 DIHYDROOROTIC ACID DEHYDROGENASE INHIBITOR エヌエーアイ株式会社 (JP) 2013-12-05 — — WO disclosed
US-20130296422-A1 Novel Dihydroxybenzene Derivatives and Antiprotozoal Agent Comprising Same as Active Ingredient ARIGEN PHARMACEUTICALS, INC. (JP) 2013-11-07 — — US disclosed
EP-2636663-A1 NOVEL DIHYDROXYBENZENE DERIVATIVES AND ANTIPROTOZOAL AGENT COMPRISING SAME AS ACTIVE INGREDIENT aRigen Pharmaceuticals, Inc. (JP) 2013-09-11 — — EP disclosed
WO-2012060387-A1 NOVEL DIHYDROXYBENZENE DERIVATIVES AND ANTIPROTOZOAL AGENT COMPRISING SAME AS ACTIVE INGREDIENT アリジェン製薬株式会社 (JP) 2012-05-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130296422-A1 Novel Dihydroxybenzene Derivatives and Antiprotozoal Agent Comprising Same as Active Ingredient CBR3, CBR1, DHX35 DHODH 16/4885MAOB 811/4885IMPDH2 2804/4885
US-20160296494-A1 DIHYDROOROTIC AND ACID DEHYDROGENASE INHIBITOR DHODH, DPYD, DLD DHODH 1/4885MAOB 1150/4885IMPDH2 110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback